AI Summary
In this report, Argaam highlights the expected results of Al Hammadi Holding Co. for the fourth quarter of 2025, as well as its key events, sales, earnings, and performance indicators.
The fourth-quarter revenue is projected to rise 0.84% year-on-year (YoY) to SAR 325.50 million.
| Item | Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 (Average Estimate) |
|---|---|---|---|---|---|
| Sales | 322.79 | 301.88 | 298.24 | 294.91 | 325.50 |
| Change % | 6.29% | 8.97% | 13.20% | 1.49% | 0.84% |
| Income from Affiliate | 2.83 | 5.49 | 7.06 | 6.67 | NA |
| Change % | (2.71%) | 26,019.05% | NA | 50.80% | NA |
| Item | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 (Average Estimate) |
|---|---|---|---|---|---|
| Net Income | 77.76 | 73.93 | 61.96 | 51.89 | 65.65 |
| Extraordinary income/expense | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Net Profit Before Unusual Items | 77.76 | 73.93 | 61.96 | 51.89 | - |
| EPS Before Unusual Items (Riyal/Share) | 0.49 | 0.46 | 0.39 | 0.32 | 0.41 |
Key events in Q4 2025
The board of directors decided to distribute 2% cash dividends, or SAR 0.20 per share, for Q3 2025.
The board also approved the company’s dividend policy for the next four years as of Q3 2025, committing to distribute at least 60% of net profits each quarter.
The company signed a share subscription agreement to acquire a 40% stake in Wareed Medical LLC for SAR 113 million. Both firms also inked a shareholder agreement to regulate relationships among shareholders and the mechanism of managing the company in the coming phase.
Average forecasts
Al Hammadi’s net profit is expected to fall 15.6% YoY to SAR 65.7 million in Q4 2025, according to estimates issued by four research firms.
| Analyst | Million Riyals |
|---|---|
| U-Capital Co. | 73.60 |
| SNB Capital Company | 65.20 |
| United Securities Company | 65.00 |
| AlJazira Capital Company | 58.80 |
| Average | 65.65 |
| Net Profit Before Unusual Items (2024 - Q4) | 77.76 |
| Change % | (15.58%) |
Performance and profitability indicators
The following table shows the stock performance trailing 12 months and year to date, as well as its P/E and earnings per share:
| Item | The Company | TASI |
|---|---|---|
| YTD | (5.58 %) | 6.30 % |
| Change(12M) | (39.19 %) | (10.08 %) |
| Previous Close | 26.32 | 11,195.45 |
| Recurring P/E (x) | 15.92 | 20.33 |
| EPS (TTM) before unusual items (SAR/Share) | 1.66 | - |
| P/E (TTM) | 15.92 |
| P/E Before Unusual Items (TTM) | 15.92 |
| P/BV | 2.13 |
| Dividend Yield | 3.65 % |
| Market Cap. (M) | 4,227.20 |
| Return on Average Assets | 10.00 % |
| Return on Average Equity | 13.54 % |
Be the first to comment
Comments Analysis: